| Moderator 主持人 | Shiliang Jiang 蒋世良, Xinchun Yang 杨新春, Tianzhu Luan 栾天竹, Xiaoxiang Yan 闫小响 | |
|
1:30 PM- |
Mitochondrial Calcium Uniporter Inhibition Provides Cardioprotection in Pressure Overload-Induced Heart Failure through Autophagy Enhancement (AS-0067) 干预MCU可影响心脏自噬从而发挥心肌保护作用（AS-0067） |
Ziqing Yu 禹子清 |
|
1:40 PM- |
Q&A 讨论 |
|
|
1:45 PM- |
FMO2 Ameliorates Cardiac Fibrosis via Inhibiting Phosphorylation of SMAD2/3 through Combining with CYP2J3 (AS-0247) 含黄素单氧化酶2通过结合细胞色素p450超家族2J3减轻SMAD2/3磷酸化介导的心脏纤维化（AS-0247） |
Cheng Ni 倪骋 |
|
1:55 PM- |
Q&A 讨论 |
|
|
2:00 PM- |
Prevalence of Modifiable Risk Factors and Relation to Stroke and Death in Patients with Atrial Fibrillation: A Report from the China Atrial Fibrillation Registry (China-AF) Study (AS-0039) 中国心房颤动患者可控危险因素现状及与卒中和死亡相关性的研究：中国心房颤动注册研究（CHINA-AF）（AS-0039） |
Chao Jiang 蒋超 |
|
2:10 PM- |
Q&A 讨论 |
|
|
2:15 PM- |
Beneficial Effects of Exercise on Asymptomatic Vascular Target Organ Damage in the Community-dwelling Elderly Chinese: The Northern Shanghai Study (AS-0109) 在中国社区老年人群中运动对高血压靶器官损害的保护作用：北上海研究（AS-0109） |
Yuyan Lu 吕煜焱 |
|
2:25 PM- |
Q&A 讨论 |
|
|
2:30 PM- |
BIOFLOW-VI: Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects with De Novo Coronary Artery Lesions (AS-0121) BIOFLOW-VI试验：Orsiro药物洗脱支架治疗冠状动脉原发病变的安全性和临床表现（AS-0121） |
Chongjian Li 李崇剑 |
|
2:40 PM- |
Q&A 讨论 |
|
|
2:45 PM- |
Comparison of Percutaneous Intramyocardial Septal Radiofrequency Ablation (Liwen Procedure) with Surgical Septal Myectomy for the Treatment of Hypertrophic Obstructive Cardiomyopathy(AS-0239) 丽文术式与外科室间隔切除术治疗梗阻性肥厚型心肌病的随访对比研究（AS-0239） |
Liwen Liu 刘丽文 |
|
2:55 PM- |
Q&A 讨论 |
|
|
3:00 PM- |
Adjourn 休会 |
|